Gland Pharma Limited — Others, 13-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Gland Pharma has confirmed receipt of a Certificate from MUFG Intime India Pvt. Ltd., validating activities related to security dematerialization for the quarter ended December 31, 2024. The confirmation states that all securities received were processed and listed on relevant stock exchanges. No requests for dematerialization or rematerialization were reported during this period. This update reflects operational efficiency in handling share transactions, potentially bolstering investor confidence. Overall, this develops a positive outlook towards the company’s compliance and operational management, keeping shareholders informed of their securities' status.